SEC Comment Letter for AIM ImmunoTech Inc. (AIM) (CIK 0000946644) (AIM) — May 26, 2009

AIM ImmunoTech Inc. (AIM) (CIK 0000946644)
Date: May 26, 2009 · CIK: 0000946644 · Accession: 0000000000-09-027768

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-13441

Date

May 26, 2009

Author

Jeff Riedler Assistant Director

Form

UPLOAD

Company

AIM ImmunoTech Inc. (AIM) (CIK 0000946644)

Letter

Via Facsimile and U.S. Mail Mail Stop 4720 May 26, 2009 Dr. William A. Carter, M.D. Chief Executive Officer Hemispherx BioPharma, Inc. 1617 JFK Boulevard Philadelphia, PA 19103 Re: Hemispherx BioPharma, Inc. Preliminary Proxy Statement on Schedule 14A Filed April 30, 2009 File Number 001-13441

Dear Dr. Carter: We have completed our review of the above listed filing and have no further comments at this time.

Sincerely,
Jeff Riedler Assistant Director

Show Raw Text

Via Facsimile and U.S. Mail
Mail Stop 4720
         May 26, 2009   Dr. William A. Carter, M.D.  Chief Executive Officer Hemispherx BioPharma, Inc. 1617 JFK Boulevard Philadelphia, PA 19103
Re: Hemispherx BioPharma, Inc.  Preliminary Proxy Statement on Schedule 14A  Filed April 30, 2009  File Number 001-13441

Dear Dr. Carter:
  We have completed our review of the above listed filing and have no further
comments at this time.

Sincerely,

Jeff Riedler Assistant Director

SecProbe.io